Making gender : big pharma, HPV vaccine policy, and women's ontological decision-making / Michelle Wyndham-West
"Making Gender endeavours to understand how the HPV vaccine became gendered within the Canadian policy landscape--when the virus is gender blind and is linked to cancer in all genders--and how women's experiences with this "gendered risk" have been folded into their vaccine decision-making. Drawing on ethnographic fieldwork and archival research, Michelle Wyndham-West explores the creation and circulation of gendered risk as it was deployed in pharmaceutical and policy discourses surrounding the rollout of the HPV vaccine. The book contextualizes the background for how gendered risk was mediated by two groups of women: mothers negotiating the vaccine for their daughters in school-based immunization programs and university students who experienced frequent HPV infections. The book explores these women's efforts to be good mothers and strong young women entering adulthood who felt vulnerable in sexual health negotiation. As a result, Making Gender reveals how vaccine decision-making took an ontological form, as an inherently social and cultural process embedded in women's experiences."--.
| Medienart: |
Buch |
|---|
| Erscheinungsjahr: |
[2023] ©2023 |
|---|---|
| Erschienen: |
Toronto Buffalo London: University of Toronto Press ; 2023 ©2023 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wyndham-West, Michelle [VerfasserIn] |
|---|
| ISBN: |
|---|
| Anmerkungen: |
Includes bibliographical references (pages 125-150) and index |
|---|
| Umfang: |
164 Seiten ; Illustrationen ; 24 cm |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
1884193781 |
|---|
| LEADER | 01000nam a2200265 4500 | ||
|---|---|---|---|
| 001 | 1884193781 | ||
| 003 | DE-627 | ||
| 005 | 20240325111810.0 | ||
| 007 | tu | ||
| 008 | 240325s2023 xxc||||| 00| ||eng c | ||
| 020 | |a 9781487509200 |c cloth |9 978-1-4875-0920-0 | ||
| 035 | |a (DE-627)1884193781 | ||
| 035 | |a (DE-599)KXP1884193781 | ||
| 035 | |a (OCoLC)1427699512 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 044 | |c XD-CA | ||
| 050 | 0 | |a QR189.5.P36 | |
| 082 | 0 | |a 616.9/11 |2 23 | |
| 100 | 1 | |a Wyndham-West, Michelle |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Making gender |b big pharma, HPV vaccine policy, and women's ontological decision-making |c Michelle Wyndham-West |
| 264 | 1 | |a Toronto |a Buffalo |a London |b University of Toronto Press |c [2023] | |
| 264 | 4 | |c ©2023 | |
| 300 | |a 164 Seiten |b Illustrationen |c 24 cm | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Includes bibliographical references (pages 125-150) and index | ||
| 505 | 8 | 0 | |a Introduction -- Navigating Controversies and Doing Mothering: Making HPV Vaccine Decisions for One's Daughter -- University-Aged Women's Experiences with HPV Infection and Vaccine Decision Making -- Media Landscape: Controversies and Competing Narratives -- Vaccine Marketing by Harnessing Hegemonic Cultural Discourses of Risk and Gender -- Gendered Vaccine Policymaking -- Conclusion: Theoretical Contributions and Reassessing Gender-Based Analysis Policymaking. |
| 520 | |a "Making Gender endeavours to understand how the HPV vaccine became gendered within the Canadian policy landscape--when the virus is gender blind and is linked to cancer in all genders--and how women's experiences with this "gendered risk" have been folded into their vaccine decision-making. Drawing on ethnographic fieldwork and archival research, Michelle Wyndham-West explores the creation and circulation of gendered risk as it was deployed in pharmaceutical and policy discourses surrounding the rollout of the HPV vaccine. The book contextualizes the background for how gendered risk was mediated by two groups of women: mothers negotiating the vaccine for their daughters in school-based immunization programs and university students who experienced frequent HPV infections. The book explores these women's efforts to be good mothers and strong young women entering adulthood who felt vulnerable in sexual health negotiation. As a result, Making Gender reveals how vaccine decision-making took an ontological form, as an inherently social and cultural process embedded in women's experiences."-- | ||
| 530 | |a Issued also in electronic format | ||
| 533 | |n Issued also in electronic format | ||
| 650 | 0 | |a Papillomavirus vaccines |z Canada | |
| 650 | 0 | |a Vaccination |z Canada |x Decision making | |
| 650 | 0 | |a Women |x Health risk assessment |z Canada | |
| 650 | 0 | |a Women college students |x Health risk assessment |z Canada | |
| 650 | 0 | |a Vaccination |x Social aspects |z Canada | |
| 650 | 0 | |a Mothers and daughters |z Canada | |
| 650 | 0 | |a Pharmaceutical industry |z Canada | |
| 650 | 0 | |a Medical policy |z Canada | |
| 650 | 4 | |a Vaccins antipapillomavirus - Canada | |
| 650 | 4 | |a Vaccination - Canada - Prise de décision | |
| 650 | 4 | |a Femmes - Risques pour la santé - Évaluation - Canada | |
| 650 | 4 | |a Étudiantes - Risques pour la santé - Évaluation - Canada | |
| 650 | 4 | |a Vaccination - Aspect social - Canada | |
| 650 | 4 | |a Mères et filles - Canada | |
| 650 | 4 | |a Industrie pharmaceutique - Canada | |
| 650 | 4 | |a Politique sanitaire - Canada | |
| 650 | 4 | |a Medical policy | |
| 650 | 4 | |a Mothers and daughters | |
| 650 | 4 | |a Papillomavirus vaccines | |
| 650 | 4 | |a Pharmaceutical industry | |
| 650 | 4 | |a Women - Health risk assessment | |
| 651 | 4 | |a Canada | |
| 776 | 1 | |z 1487539908 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |a Wyndham-West, Michelle |t Making gender |d Toronto : University of Toronto Press, 2023 |z 1487539908 |z 9781487539900 |
| 912 | |a GBV_ILN_40 | ||
| 912 | |a ISIL_DE-7 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 951 | |a BO | ||
| 953 | |2 045F |a 616.9/11 | ||
| 980 | |2 40 |1 01 |x 7/11 |b 4503449958 |c 00 |f BBM |d XS 451 313 = 2024 A 28485 |e u |j --%%-- |c 09 |f --%%-- |d 2024 A 28485 |e --%%-- |j --%%-- |h SE-DH |y ksn |z 25-03-24 | ||
| 983 | |2 40 |1 00 |x DE-7 |8 00 |0 (DE-627)619876069 |a MED 451 |b Gynäkologie | ||
| 983 | |2 40 |1 00 |x DE-7 |8 01 |0 (DE-627)619875410 |a MED 336 |b Impfung | ||
| 984 | |2 40 |1 01 |x 7/11 |a 7$239028694 | ||
| 995 | |2 40 |1 01 |x 7/11 |a SE-DH | ||
| 998 | |2 40 |1 01 |x 7/11 |0 2024-03 | ||